Clinical trials
Phase 2 Genetic Diseases, Inborn trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 2 |
| 2014 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 10 |
| Terminated | 4 |
| Enrolling by invitation | 3 |
| Recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 3 |
| QED Therapeutics, a BridgeBio company | 3 |
| Vertex Pharmaceuticals Incorporated | 3 |
| Akcea Therapeutics | 1 |
| Alexion Pharmaceuticals, Inc. | 1 |
| Biossil Inc. | 1 |
| Eloxx Pharmaceuticals, Inc. | 1 |
| Forma Therapeutics, Inc. | 1 |
| Laboratoires Thea | 1 |
| McMaster University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Genetic Diseases, Inborn | 19 |
| Musculoskeletal Diseases | 5 |
| Bone Diseases | 3 |
| Fragile X Syndrome | 3 |
| Infant, Newborn, Diseases | 3 |
| Metabolic Diseases | 3 |
| Mucopolysaccharidosis IV | 3 |
| Osteochondrodysplasias | 3 |
| Achondroplasia | 2 |
| Anemia | 2 |
Trials
Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.